Literature DB >> 19995835

Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report.

Jared M Bruce1, Laura M Hancock, Sharon G Lynch.   

Abstract

Poor adherence to medication is commonplace and contributes to poor health outcomes among numerous patient populations. Studies that have examined treatment adherence in multiple sclerosis focus exclusively on retrospective self-reports and/or imprecise measures of treatment discontinuation. To help address these methodological limitations, the present longitudinal study compared adherence outcomes for patients with multiple sclerosis using retrospective self-reports, adherence diaries, and a novel electronic monitoring device. Sixty-seven patients with relapsing-remitting multiple sclerosis were followed for a period of eight weeks during which they used a medication diary and a sharps container that captured electronically the time and date of each needle disposal. The patients also reported at the outset and conclusion of the study how frequently they missed doses. All measures of adherence were highly correlated. Patients reported better adherence than was indicated by medication diaries and electronic monitoring of needle disposals. Nearly one-fifth of the sample exhibited poor adherence, missing more than 20% of their prescribed medication. The results support the validity of electronic monitoring of needle disposal as an effective means of measuring adherence to disease modifying therapies in multiple sclerosis. In contrast, studies employing only self-report may underestimate poor adherence. Larger scale studies that employ prospective objective methods are necessary to gain a better understanding of adherence patterns in multiple sclerosis.

Entities:  

Mesh:

Year:  2009        PMID: 19995835     DOI: 10.1177/1352458509351897

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  28 in total

1.  A multicenter study of the predictors of adherence to self-injected glatiramer acetate for treatment of relapsing-remitting multiple sclerosis.

Authors:  Howard Zwibel; Gabriel Pardo; Shelly Smith; Douglas Denney; Merrikay Oleen-Burkey
Journal:  J Neurol       Date:  2010-10-06       Impact factor: 4.849

2.  Facilitating medication adherence in patients with multiple sclerosis.

Authors:  Gina Remington; Yolanda Rodriguez; Diana Logan; Caroline Williamson; Katherine Treadaway
Journal:  Int J MS Care       Date:  2013

3.  Multiple sclerosis: MS treatment adherence--how to keep patients on medication?

Authors:  Jared M Bruce; Sharon G Lynch
Journal:  Nat Rev Neurol       Date:  2011-07-05       Impact factor: 42.937

4.  Baseline predictors of DMT reinitiation among patients with multiple sclerosis following an MI-CBT intervention.

Authors:  Joanie Thelen; Amanda Bruce; Delwyn Catley; Sharon Lynch; Kathy Goggin; Andrea Bradley-Ewing; Morgan Glusman; Abigail Norouzinia; Lauren Strober; Jared Bruce
Journal:  J Behav Med       Date:  2017-11-09

5.  Preferences for Multiple Sclerosis Treatments: Using a Discrete-Choice Experiment to Examine Differences Across Subgroups of US Patients.

Authors:  Carol Mansfield; Nina Thomas; David Gebben; Maria Lucas; A Brett Hauber
Journal:  Int J MS Care       Date:  2017 Jul-Aug

6.  Exacerbation history is associated with medication and appointment adherence in MS.

Authors:  Laura M Hancock; Jared M Bruce; Sharon G Lynch
Journal:  J Behav Med       Date:  2011-01-23

7.  Longitudinal changes in magnetisation transfer ratio in secondary progressive multiple sclerosis: data from a randomised placebo controlled trial of lamotrigine.

Authors:  T Hayton; J Furby; K J Smith; D R Altmann; R Brenner; J Chataway; K Hunter; D J Tozer; D H Miller; R Kapoor
Journal:  J Neurol       Date:  2011-09-09       Impact factor: 4.849

8.  Treatment adherence and transitioning youth in pediatric multiple sclerosis.

Authors:  Sabeen Lulu; Laura Julian; Emma Shapiro; Kyr Hudson; Emmanuelle Waubant
Journal:  Mult Scler Relat Disord       Date:  2014-11       Impact factor: 4.339

9.  A pilot study to improve adherence among MS patients who discontinue treatment against medical advice.

Authors:  Jared Bruce; Amanda Bruce; Sharon Lynch; Lauren Strober; Sean O'Bryan; Deborah Sobotka; Joan Thelen; Abigail Ness; Morgan Glusman; Kathy Goggin; Andrea Bradley-Ewing; Delwyn Catley
Journal:  J Behav Med       Date:  2015-11-12

10.  Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence.

Authors:  Helen P Pizzo; Robert B Ettenger; David W Gjertson; Elaine F Reed; Jennifer Zhang; H Albin Gritsch; Eileen W Tsai
Journal:  Pediatr Nephrol       Date:  2016-06-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.